SCHEMBL4713611

SCHEMBL4713611

NC(=O)c1cccc(/C=C/c2ccccc2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 6/20 0.62
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 4/20 0.53
HDAC6 Q9UBN7 3/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
PKM P14618 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
HPGD P15428 3/20 0.53
GRM5 P41594 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
CYP2C19 P33261 1/20 0.53
THPO P40225 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4713613 1.00 GRM4 (0.62) GRM4KDM4EALDH1A1HDAC6NPC1
SCHEMBL2597811 0.86 GRM4 (0.61) GRM4KDM4EALDH1A1HDAC6NPC1
SCHEMBL2597810 0.86 GRM4 (0.61) GRM4KDM4EALDH1A1HDAC6NPC1
SCHEMBL4711170 0.83 GRM4 (0.57) GRM4KDM4EALDH1A1HDAC6NPC1
SCHEMBL4711172 0.83 GRM4 (0.57) GRM4KDM4EALDH1A1HDAC6NPC1
SCHEMBL9779548 0.80 HDAC6 (0.61) KDM4EALDH1A1HDAC6NPC1RAB9A
SCHEMBL9779550 0.80 HDAC6 (0.61) KDM4EALDH1A1HDAC6NPC1RAB9A
SCHEMBL4710117 0.80 NPC1 (0.56) GRM4KDM4EALDH1A1HDAC6NPC1
SCHEMBL4710118 0.80 NPC1 (0.56) GRM4KDM4EALDH1A1HDAC6NPC1
SCHEMBL27537819 0.79 GRM4 (0.52) GRM4KDM4EALDH1A1HDAC6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed
US-6656957-B1 Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. NOVARTIS AG (CH) 2003-12-02 US disclosed